• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Increased platelet retention in familial recurrent thrombotic thrombocytopenic purpura.

作者信息

Karpman D, Holmberg L, Jirgård L, Lethagen S

机构信息

Department of Pediatrics, University of Lund, Sweden.

出版信息

Kidney Int. 1996 Jan;49(1):190-9. doi: 10.1038/ki.1996.26.

DOI:10.1038/ki.1996.26
PMID:8770967
Abstract

We studied two brothers with recurrent thrombotic thrombocytopenic purpura (TTP). Platelet retention, measured with a modified Adeplat S glass-bead test, was found to be increased during acute episodes of TTP and during remissions. Values of platelet retention ranged between 57 to 95% (normal range 16 to 34%). The continually elevated values enabled us to investigate which fraction of the patients' blood was responsible for the increased platelet retention and to evaluate the effect of different treatments on this parameter. We found that the patients' plasma increased the retention of normal platelets and of platelets taken from a patient with von Willebrand's disease type III. This activity was located in the cryoprecipitate fraction of plasma. Unusually large von Willebrand factor (vWF) multimers were demonstrated in both children during remission and decreased during relapse. Both fresh frozen plasma (FFP) and a commercial factor VIII/vWF concentrate reduced platelet retention when tested during remission. Treatment of both siblings with FFP or factor VIII/vWF concentrate was beneficial during recurrences. We conclude that the elevated platelet retention is due to a factor in the cryoprecipitate of the childrens' plasma, and that both FFP and factor VIII/vWF concentrate are effective in decreasing platelet retention.

摘要

相似文献

1
Increased platelet retention in familial recurrent thrombotic thrombocytopenic purpura.
Kidney Int. 1996 Jan;49(1):190-9. doi: 10.1038/ki.1996.26.
2
von Willebrand factor mediates increased platelet retention in recurrent thrombotic thrombocytopenic purpura.血管性血友病因子介导复发性血栓性血小板减少性紫癜中血小板滞留增加。
Thromb Haemost. 1997 Dec;78(6):1456-62.
3
Effects of fresh-frozen plasma and its cryosupernatant fraction on von Willebrand factor multimeric forms in chronic relapsing thrombotic thrombocytopenic purpura.新鲜冰冻血浆及其冷上清组分对慢性复发性血栓性血小板减少性紫癜中血管性血友病因子多聚体形式的影响。
Blood. 1985 May;65(5):1232-6.
4
Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.血栓性血小板减少性紫癜和溶血尿毒综合征中血管性血友病因子多聚体的异常。
Am J Med. 1989 Sep;87(3N):9N-15N.
5
Heat-treated factor VIII/von Willebrand factor concentrate in platelet-type von Willebrand's disease.血小板型血管性血友病中经热处理的凝血因子 VIII/血管性血友病因子浓缩物
Haemostasis. 1987;17(6):353-60. doi: 10.1159/000215770.
6
Effect of cryoprecipitate and plasma on plasma von Willebrand factor multimeters and bleeding time in Doberman Pinschers with type-I von Willebrand's disease.冷沉淀和血浆对患有I型血管性血友病的杜宾犬血浆血管性血友病因子多聚体及出血时间的影响
Am J Vet Res. 1994 Jan;55(1):102-10.
7
Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura.与噻氯匹定相关的血栓性血小板减少性紫癜中血管性血友病因子金属蛋白酶的抗体抑制剂及血管性血友病因子与血小板结合增加
Ann Intern Med. 2000 May 16;132(10):794-9. doi: 10.7326/0003-4819-132-10-200005160-00005.
8
ADAMTS13 content in plasma-derived factor VIII/von Willebrand factor concentrates.血浆源性因子 VIII/von Willebrand 因子浓缩物中的 ADAMTS13 含量。
Am J Hematol. 2013 Oct;88(10):895-8. doi: 10.1002/ajh.23527. Epub 2013 Aug 30.
9
Von Willebrand factor--cleaving protease activity in congenital thrombotic thrombocytopenic purpura.血管性血友病因子裂解蛋白酶活性与先天性血栓性血小板减少性紫癜
Br J Haematol. 2000 Dec;111(4):1215-22. doi: 10.1046/j.1365-2141.2000.02503.x.
10
Thrombosis and von Willebrand Factor.血栓形成与血管性血友病因子
Adv Exp Med Biol. 2017;906:285-306. doi: 10.1007/5584_2016_122.

引用本文的文献

1
Red blood cell-derived arginase release in hemolytic uremic syndrome.溶血尿毒综合征中红细胞衍生的精氨酸酶释放。
J Transl Med. 2024 Jan 4;22(1):17. doi: 10.1186/s12967-023-04824-x.
2
Neutrophil Protease Cleavage of Von Willebrand Factor in Glomeruli - An Anti-thrombotic Mechanism in the Kidney.中性粒细胞蛋白酶在肾小球中对血管性血友病因子的切割 - 肾脏中的一种抗血栓机制。
EBioMedicine. 2017 Feb;16:302-311. doi: 10.1016/j.ebiom.2017.01.032. Epub 2017 Jan 24.
3
Complement activation associated with ADAMTS13 deficiency in human and murine thrombotic microangiopathy.
补体激活与人类和鼠类血栓性微血管病中 ADAMTS13 缺乏相关。
J Immunol. 2013 Sep 1;191(5):2184-93. doi: 10.4049/jimmunol.1301221. Epub 2013 Jul 22.
4
Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜中ADAMTS13功能障碍的分子基础。
Pediatr Nephrol. 2009 Mar;24(3):447-58. doi: 10.1007/s00467-008-0986-8. Epub 2008 Sep 20.
5
ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpura.正常个体和血栓性血小板减少性紫癜患者血浆中的ADAMTS13表型。
Eur J Pediatr. 2007 Mar;166(3):249-57. doi: 10.1007/s00431-006-0354-2. Epub 2006 Dec 24.
6
Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome.血管性血友病因子裂解蛋白酶与舒-尤二氏综合征
Int J Hematol. 2002 Jan;75(1):25-34. doi: 10.1007/BF02981975.